Francisco X Real
Francisco X Real
Senior Group Leader, CNIO, Madrid; Professor of Cell Biology, Universitat Pompeu Fabra, Barcelona
Verified email at
Cited by
Cited by
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ...
Gut 62 (3), 339-347, 2013
A consensus molecular classification of muscle-invasive bladder cancer
A Kamoun, A de Reyničs, Y Allory, G Sjödahl, AG Robertson, R Seiler, ...
European urology 77 (4), 420-433, 2020
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ...
The Lancet 366 (9486), 649-659, 2005
Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools
CM Villanueva, KP Cantor, JO Grimalt, N Malats, D Silverman, A Tardon, ...
American journal of epidemiology 165 (2), 148-156, 2007
Detectable clonal mosaicism and its relationship to aging and cancer
KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ...
Nature genetics 44 (6), 651-658, 2012
Comprehensive transcriptional analysis of early-stage urothelial carcinoma
J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Hřyer, BP Ulhři, S Vang, ...
Cancer cell 30 (1), 27-42, 2016
Addressing the challenges of pancreatic cancer: future directions for improving outcomes
M Hidalgo, S Cascinu, J Kleeff, R Labianca, JM Löhr, J Neoptolemos, ...
Pancreatology 15 (1), 8-18, 2015
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ...
Nature 538 (7625), 378-382, 2016
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ...
Nature genetics 42 (11), 978-984, 2010
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma
SE Krown, FX Real, S Cunningham-Rundles, PL Myskowski, B Koziner, ...
New England Journal of Medicine 308 (18), 1071-1076, 1983
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4
PS Moore, B Sipos, S Orlandini, C Sorio, FX Real, NR Lemoine, T Gress, ...
Virchows Archiv 439, 798-802, 2001
Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas
S Hernández, E López-Knowles, J Lloreta, M Kogevinas, A Amorós, ...
Journal of Clinical Oncology 24 (22), 3664-3671, 2006
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
N Malats, A Bustos, CM Nascimento, F Fernandez, M Rivas, D Puente, ...
The lancet oncology 6 (9), 678-686, 2005
Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage
M Porta, X Fabregat, N Malats, L Guarner, A Carrato, A De Miguel, L Ruiz, ...
Clinical and Translational Oncology 7, 189-197, 2005
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma
CR Divgi, S Welt, M Kris, FX Real, SDJ Yeh, R Gralla, B Merchant, ...
JNCI: Journal of the National Cancer Institute 83 (2), 97-104, 1991
Epidemiology of urinary bladder cancer: from tumor development to patient’s death
C Murta-Nascimento, BJ Schmitz-Dräger, MP Zeegers, G Steineck, ...
World journal of urology 25, 285-295, 2007
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ...
Nature genetics 46 (9), 994-1000, 2014
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
C Balbás-Martínez, A Sagrera, E Carrillo-de-Santa-Pau, J Earl, ...
Nature genetics 45 (12), 1464-1469, 2013
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
L Groesser, E Herschberger, A Ruetten, C Ruivenkamp, E Lopriore, ...
Nature genetics 44 (7), 783-787, 2012
The system can't perform the operation now. Try again later.
Articles 1–20